Novel insights into the effects of diabetes on gastric motility (Q38662831)

5 September 2017

Novel insights into the effects of diabetes on gastric motility (English)

1 reference

5 September 2017

3

1 reference

5 September 2017

Chinmay S Marathe

1

1 reference

PubMed ID

26647088

5 September 2017

Christopher K Rayner

series ordinal

2

1 reference

PubMed ID

26647088

5 September 2017

Michael Horowitz

series ordinal

4

1 reference

5 September 2017

8 December 2015

1 reference

Expert Review of Gastroenterology & Hepatology

5 September 2017

1 reference

5 September 2017

10

1 reference

5 September 2017

581-593

1 reference

5 September 2017

5

1 reference

Clinical guideline: management of gastroparesis

5 September 2017

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Relationships between gastric emptying, postprandial glycemia, and incretin hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Insulin-induced hypoglycemia accelerates gastric emptying of solids and liquids in long-standing type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Interstitial cells: regulators of smooth muscle function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Gut motility and enteroendocrine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Rapid gastric emptying of a solid pancake meal in type II diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Gastric Emptying Is More Rapid in Adolescents With Type 1 Diabetes and Impacts on Postprandial Glycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Delayed Gastric Emptying Is Associated With Early and Long-term Hyperglycemia in Type 1 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Gastric emptying and glycaemia in health and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Diabetic gastroparesis: functional/morphologic background, diagnosis, and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Histologic changes in diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Cellular changes in diabetic and idiopathic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Reduced insulin and IGF-I signaling, not hyperglycemia, underlies the diabetes-associated depletion of interstitial cells of Cajal in the murine stomach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Future directions in the treatment of gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Sepiapterin reverses the changes in gastric nNOS dimerization and function in diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Abnormal initiation and conduction of slow-wave activity in gastroparesis, defined by high-resolution electrical mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Altered expression of Ano1 variants in human diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Oxidative stress: key player in gastrointestinal complications of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Heme oxygenase -1 gene therapy: recent advances and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Association of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Predictors of delayed gastric emptying in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Loss of Interstitial Cells of Cajal and Patterns of Gastric Dysrhythmia in Patients With Chronic Unexplained Nausea and Vomiting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Outcomes and Factors Associated With Reduced Symptoms in Patients With Gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

A small particle size diet reduces upper gastrointestinal symptoms in patients with diabetic gastroparesis: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Prokinetics in patients with gastroparesis: a systematic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Ghrelin and motilin receptors as drug targets for gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Gastric electrical stimulation improves outcomes of patients with gastroparesis for up to 10 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Gastroparesis: pathogenesis, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Hyperglycaemia stimulates pyloric motility in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

The nitric oxide synthase inhibitor, Ng-nitro-L-arginine-methyl-ester, attenuates the delay in gastric emptying induced by hyperglycaemia in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Coupling and propagation of normal and dysrhythmic gastric slow waves during acute hyperglycaemia in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Hyperglycemia induces abnormalities of gastric myoelectrical activity in patients with type I diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

A 25-year longitudinal evaluation of gastric emptying in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Effect of altering gastric emptying on postprandial plasma glucose concentrations following a physiologic meal in type-II diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Differential incretin effects of GIP and GLP-1 on gastric emptying, appetite, and insulin-glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Effects of glucagon-like peptide-1 and feeding on gastric volumes in diabetes mellitus with cardio-vagal dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Effects of exogenous glucagon-like peptide-1 on gastric emptying and glucose absorption in the critically ill: relationship to glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Clinical significance, pathogenesis, and management of postprandial hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

Acarbose attenuates the hypotensive response to sucrose and slows gastric emptying in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2016.1129898

10.1586/17474124.2016.1129898

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

26647088